Medical AI is an artificial intelligence capable of predicting diseases
Palm Beach, FL – DeLorean Artificial Intelligence, Inc. has announced that its Medical AI product is the first AI in the world to be biologically validated by a third party review.
“This announcement is truly a pivotal moment not only in the field of Artificial Intelligence but healthcare as well,” said Dr. Severence MacLaughlin, founder & CEO of DeLorean AI. “This is the first time that an AI model’s predictions and forecasts have been confirmed to be accurate by a third party. Now that we know the technology readily available and evidence based, we can do the hard work of fixing the broken healthcare system of the United States.”
The validation means predictions and forecasts generated by Medical AI have been confirmed by a third party laboratory through blood tests and hospitalization follow up.
Medical AI is an artificial intelligence product that predicts diseases onset and transition, as well as next best treatments for Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD), Diabetes and Cardiovascular Disease (CVD).
Medical AI can predict when someone will develop CKD, Diabetes or CVD, as well as if a patient will get sicker and require more care or transition to a more serious disease. The technology also helps patients, physicians, healthcare professionals and health insurance companies develop the next best action or treatment modality to avert the disease with early detection, which could extend life span, quality of life and quality of care.
“The future advancements in medical technology will come from our ability to move from human scale to machine scale,” noted R. “Ray” Wang, CEO of Constellation Research, inc. “Technologies such as Medical AI augment human capabilities and create a future where we can trust both the machine and the human to make the best decisions.”
Now that predictions and forecasts made by DeLorean AI’s Medical AI have been confirmed a third party, healthcare professionals can provide early detection of chronic diseases, which will allow patients to live longer and healthier lives.
“The DeLorean AI solution provides for improved value-based care with AI and has the ability to significantly improve patient outcomes,” said Rodrigo Liang, CEO and co-founder of SambaNova Systems.
As we approach the enrollment season for healthcare before you sign up with health insurance, you need to ask if the health insurance company has adopted AI or other advanced technologies to forecast you and your family’s health. For companies that self insure this is an important milestone to provide your employees with tools to improve their quality of care and life.
Peter Page is the Contributions Editor at Grit Daily. Formerly at Entrepreneur.com, he began his journalism career as a newspaper reporter long before print journalism had even heard of the internet, much less realized it would demolish the industry. The years he worked a police reporter are a big influence on his world view to this day. Page has some degree of expertise in environmental policy, the energy economy, ecosystem dynamics, the anthropology of urban gangs, the workings of civil and criminal courts, politics, the machinations of government, and the art of crystallizing thought in writing.
Credit: Source link
Comments are closed.